Lotus Clinical Research®, LLC has developed proprietary materials for patient education and staff training that consistently increase effect size by minimizing variability and placebo response in analgesic clinical trials.

Established in 2001, Lotus operates a 40-bed, Phase 1-3 privately owned research unit located on the 675-bed Huntington Hospital campus in Pasadena, California. Our specialties include Analgesics (Acute and Chronic Pain), Phase 1/Proof-of Concept, Opioid-Induced Constipation, Hospital-based Populations, Post-Operative Nausea and Vomiting, and Topical Hemostasis. Since our inception in 2001, Lotus has been inspected by the FDA on 3 occasions. All three of these not-for-cause audits results in positive comments with no 483s issued. Our position inside a major metropolitan hospital provides unprecedented access to all medical specialties / therapeutic areas and state of the art medical equipment. Our geographical location in greater Los Angeles County allows us to easily recruit from a large and ethnically diverse population of subjects.

Nearly all hospital based research units are owned by the parent institution, which inevitably leads to an extended contracting process and a pain staking local IRB review cycle. Lotus has a unique private ownership business model which allows it to contract independently and utilize a central IRB, bypassing institutional bureaucracy for rapid study starts.